Bristol Myers Squibb Partners with Microsoft to Advance Early Lung Cancer Detection with AI

Bristol Myers Squibb has partnered with Microsoft to develop an AI-powered early detection system for lung cancer. The collaboration aims to accelerate early detection and improve patient outcomes, particularly in medically underserved communities. The system will deploy FDA-cleared radiology AI algorithms via Microsoft's Precision Imaging Network, helping to identify lung nodules and guide patients to optimal care pathways.